Correction: Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review

Br J Cancer. 2025 Jan;132(1):137. doi: 10.1038/s41416-024-02920-3.

Bishma Jayathilaka^{1

2

3}, Farah Mian⁴, Fanny Franchini⁵, George Au-Yeung^{6

7}, Maarten IJzerman^{6

5

8}

¹ Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. [email protected].
² Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia. [email protected].
³ Cancer Health Services Research Unit, Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia. [email protected].
⁴ Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
⁵ Cancer Health Services Research Unit, Centre for Cancer Research, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
⁶ Sir Peter MacCallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, VIC, Australia.
⁷ Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
⁸ Erasmus School of Health Policy & Management, Erasmus University, Rotterdam, The Netherlands.

No abstract available

Publication types